TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Cochlear Limited says its Nucleus Nexa System has been named to TIME’s Best Inventions of 2026 list. The cochlear implant system features upgradeable firmware within the implanted device, but the recognition does not establish clinical outcomes or explain what future upgrades will be available.
Cochlear Limited announced that its Nucleus Nexa System has been named to TIME’s Best Inventions of 2026 list, drawing wider attention to a cochlear implant system that includes upgradeable firmware inside the implant. The recognition is an editorial selection; the announcement does not provide new clinical findings or details about future software upgrades.
The company said TIME’s editors nominated the Nucleus Nexa System for consideration. TIME gathered nominations from its editors and correspondents around the world and accepted direct applications for the 2026 list, according to the report published by The Hearing Review. TIME paid particular attention to growing fields including health care and artificial intelligence when selecting honorees.
The system’s distinguishing feature, as described in the source report, is upgradeable firmware within the implanted component. Cochlear said this allows future technology development to be delivered through both the implant and the external sound processor. The report did not identify specific upgrades, when they might become available, or how recipients would access them.
Dig Howitt, Cochlear’s chief executive and president, said the company designed Nexa as a platform intended to accommodate future technology. His statement describes the company’s goals for the system; it is not independent evidence of particular future capabilities or patient outcomes.
Recognition for Upgradeable Implant Technology
The selection gives the Nucleus Nexa System recognition beyond the hearing implant industry and puts attention on a design approach that may affect how implant technology is updated. In the model described by Cochlear, firmware in the implanted device could provide a route for future changes alongside updates to an external sound processor, rather than relying only on the processor for technological development.
For people considering or using cochlear implants, the distinction may matter because the implanted component is placed surgically, while external processors can be replaced or updated separately. However, the TIME recognition itself does not show that Nexa improves hearing compared with other systems, extends device life, or reduces the need for medical procedures. The source material provides no comparative clinical data, and readers should not interpret an award listing as proof of those benefits.
The announcement also matters to the industry because it highlights a shift in how manufacturers may design implant platforms. Whether firmware upgrades translate into practical advantages will depend on the upgrades offered, their safety and performance, compatibility, and access arrangements—all details that remain unspecified in the report.
As an affiliate, we earn on qualifying purchases.
How Nexa Differs From Earlier Systems
The Hearing Review’s report describes cochlear implant innovation as traditionally being delivered largely through the external sound processor, while the implanted component remained fixed after surgery. Cochlear says Nexa changes that approach by adding upgradeable firmware to the implant itself, with future development intended to reach both implanted and external components.
Cochlear Limited, listed on the Australian Securities Exchange as ASX: COH, was founded following Professor Graeme Clark’s development of the multi-channel cochlear implant. The company says it has helped more than 800,000 people in over 180 countries hear since 1981 and has invested more than A$3 billion in research and development. Those figures are company background, not measures of the Nexa System’s performance.
TIME’s annual Best Inventions list is assembled through nominations from its editorial staff and correspondents, along with direct applications, according to the source report. Inclusion is a media recognition, not a regulatory decision or clinical recommendation.
“With the Nucleus Nexa System, we set out to create a cochlear implant platform designed not just for the technology of today, but for the possibilities of tomorrow.”
— Dig Howitt, CEO and president of Cochlear
As an affiliate, we earn on qualifying purchases.
Upgrade Details Remain Unspecified
The announcement and source report do not say what firmware updates are planned, when they could be released, or which existing or future recipients would be eligible. They also do not explain whether upgrades would require a clinical appointment, whether any fees would apply, or how long the implanted system could receive software support.
No clinical trial results, independent evaluations, or comparisons with other cochlear implant systems are included in the material. The report likewise does not specify the product’s availability by country or provide information about regulatory status in particular markets. TIME’s selection confirms the system’s inclusion on the 2026 list, but does not resolve these product and evidence questions.
best cochlear implant sound processor
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Availability and Updates to Watch
The next information readers may look for is Cochlear’s guidance on the system’s availability, the upgrade process, and the functions that firmware changes may add. Details on eligibility, support, costs, and any relevant regulatory clearances would help recipients and clinicians understand what the upgradeable design means in practice.
For now, the confirmed development is TIME’s recognition of the Nucleus Nexa System and Cochlear’s description of its upgradeable implant firmware. The source report identifies no upcoming product milestone or release date for a firmware update, so the timing and practical effects of future changes remain open.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did TIME recognize?
TIME named Cochlear Limited’s Nucleus Nexa System to its Best Inventions of 2026 list. The source report says TIME’s editors nominated the system for consideration.
What is the system’s reported distinguishing feature?
Cochlear says the system has upgradeable firmware within the implanted component, allowing future technology development to be delivered through the implant as well as the external sound processor.
Does the TIME listing show that Nexa improves hearing outcomes?
No clinical outcome evidence is given in the source material. The listing is an editorial recognition and should not be treated as proof that the system performs better than other implants.
When will firmware upgrades be available?
The report does not give a release schedule, describe specific planned upgrades, or explain which recipients would be eligible. Cochlear’s announcement, as reported, leaves those details unanswered.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
